Postoperative Outcomes Within Enhanced Recovery After Surgery Protocol in Elective Total Hip and Knee Arthroplasty. POWER.2 Study: Study Protocol for a Prospective, Multicentre, Observational Cohort Study

• DOI: 10.5152/tjar.2019.87523
• Publication Date: 2019-02-12T13:34:46Z
• Authors: Javier Ripolles-M...; ; ; ; Ane Abad-Motos; ; Margarita Logrono...; ; Cesar Aldecoa; ; Jose Antonio Garc...; ; Ignacio Jimenez-L...; ; Concepcion Cassin...; ; Oliver Marin-Pena; ; Carlos Ferrando-O...; ; Alejandro Suarez ...; ; Manuel A. Gomez-Rios; ; Ruben Sanchez-Martin; ; Alfredo Abad-Guru...; ; Ruben Casans-Frances; ; Ana Mugarra-Llopis; ; Marina Varela-Duran; ; Javier Longas-Vailen; ; Alvaro Ramiro-Ruiz; ; Ana B. Cuellar-Ma...; ; Jose M. Ramirez-R...; ; Jose M. Calvo-Vecino
• Keywords: 03 medical and health sciences; 0302 clinical medicine; hip; arthroplasty; knee; replacement; follow-up studies; outcome and process assessment (health care); Arthroplasty; 3. Good health

The number of indications for total hip replacement (THR) and knee (TKR) surgery is increasing. Enhanced recovery after (ERAS) represents the next step in evolution standardised care. primary aim this study to measure in-hospital 30-day medical surgical postoperative complications rate. study's secondary aims are determine length stay, mortality rate, reoperation readmission rates, ERAS overall compliance predefined individual items compliance.This multicentre, prospective, observational will include adult patients (aged >18 years) undergoing elective THR TKR surgery. Consecutive within 2-month data collection period be included. Centres that offer and/or eligible participate. done through an online form via a secure, password-protected platform at each centre with fields.Ethical approval has been obtained from Comité de Ética la Investigación Comunidad Autónoma Aragón (C.P.-C.I. PI18/135; on 23 May 2018). It was prospectively registered 27 June 2018, www.clinicaltrials.gov identification no. NCT03570944.The disseminated SPARN-RedGERM, SEDAR, GERM social media. Peer-reviewed publications published under corporate authorship, including POWER.2 Study Group SPARN-RedGERM.